A recent nationally representative study published in JAMA Internal Medicine
found that previously reported declines in prostate-specific antigen (PSA) testing have not continued in recent years, and that approximately one-third of men age 50 years or older still receive routine PSA tests.1
The study noted that continued evaluation on how testing patterns influence prostate cancer outcomes over the long term are still needed.
- Fedewa SA, Ward EM, Brawley O, Jemal A. Recent patterns of prostate-specific antigen testing for prostate cancer screening in the United States. JAMA Intern Med. Published online April, 24, 2017. doi: 10.1001/jamainternmed.2017.0340
- Jemal A, Fedewa SA, Ma J, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA. 2015;314(19):2054-2061. doi: 10.1001/jama.2015.14905
- Hu JC, Nguyen P, Mao J, et al. Increase in prostate cancer distant metastases at diagnosis in the United States. JAMA Oncol. Published online December 29, 2016. doi: 10.1001/jamaoncol.2016.5465.
... to read the full story